Paraoxonase enzyme and polymorphisms

Paraoxonase (PON1) is a calcium-dependent enzyme carried on high-density lipoprotein particles that helps protect lipids from oxidative damage, and its activity has been linked to the progression of atherosclerosis and the broader risk of cardiovascular disease. Researchers in clinical biochemistry study how common single-nucleotide polymorphisms in the PON1 gene alter both the amount of enzyme produced and its catalytic efficiency, creating measurable differences in antioxidant capacity between individuals. Because low PON1 activity correlates with increased lipid peroxidation and inflammation in arterial walls, understanding which genetic variants drive these differences could clarify why cardiovascular risk varies so markedly across populations with similar HDL cholesterol levels. Active work is now focused on whether PON1 activity can serve as a practical biomarker for disease risk and on whether dietary, pharmacological, or gene-based interventions can reliably restore protective enzyme function.

Works

10,333

Total citations

197,857

Keywords

ParaoxonaseAtherosclerosisOxidative StressAntioxidantCardiovascular DiseaseGenetic Polymorphisms